Global Influenza Therapeutics Market Research Report 2025(Status and Outlook)

March 2025 | 221 pages | ID: G8A17CE39B27EN
Bosson Research

Abstracts

Report Overview

Influenza, commonly known as the flu, is an infectious disease caused by an influenza virus.

This report provides a deep insight into the global Influenza Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Influenza Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Influenza Therapeutics market in any manner.

Global Influenza Therapeutics Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Abbott Laboratories

Astrazeneca PLC

Biocryst Pharmaceuticals

Inc.

Chiron Corporation

CSL Limited

Daiichi Sankyo Co.

Ltd.

Glaxosmithkline PLC

Mitsubishi Tanabe Pharma Corporation

Nanotherapeutics Inc.

Protein Sciences Corporation

Roche Holding AG

Sanofi SA

Shionogi & Co.

Ltd.

Sinovac Biotech Ltd.

Market Segmentation (by Type)

Vaccines

Drugs

Market Segmentation (by Application)

Hospitals

Clinic

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Influenza Therapeutics Market
• Overview of the regional outlook of the Influenza Therapeutics Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Influenza Therapeutics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Influenza Therapeutics
1.2 Key Market Segments
1.2.1 Influenza Therapeutics Segment by Type
1.2.2 Influenza Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Influenza Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global Influenza Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Influenza Therapeutics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Influenza Therapeutics Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Influenza Therapeutics Product Life Cycle
3.3 Global Influenza Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Influenza Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Influenza Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Influenza Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Influenza Therapeutics Manufacturing Sites, Area Served, Product Type
3.8 Influenza Therapeutics Market Competitive Situation and Trends
3.8.1 Influenza Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Influenza Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Influenza Therapeutics Industry Chain Analysis
4.1 Influenza Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Influenza Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Influenza Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Influenza Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 Global Influenza Therapeutics Market by Region
6.1 Global Influenza Therapeutics Market Size by Region
6.1.1 Global Influenza Therapeutics Market Size by Region
6.1.2 Global Influenza Therapeutics Market Size Market Share by Region
6.2 Global Influenza Therapeutics Sales by Region
6.2.1 Global Influenza Therapeutics Sales by Region
6.2.2 Global Influenza Therapeutics Sales Market Share by Region
7 North America Market Overview
7.1 North America Influenza Therapeutics Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Influenza Therapeutics Market Size by Type
7.3 North America Influenza Therapeutics Market Size by Application
8 Europe Market Overview
8.1 Europe Influenza Therapeutics Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Influenza Therapeutics Market Size by Type
8.3 Europe Influenza Therapeutics Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Influenza Therapeutics Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Influenza Therapeutics Market Size by Type
9.3 Asia-Pacific Influenza Therapeutics Market Size by Application
10 South America Market Overview
10.1 South America Influenza Therapeutics Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Influenza Therapeutics Market Size by Type
10.3 South America Influenza Therapeutics Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Influenza Therapeutics Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Influenza Therapeutics Market Size by Type
11.3 Middle East and Africa Influenza Therapeutics Market Size by Application
12 Influenza Therapeutics Market Production by Region
12.1 Global Production of Influenza Therapeutics by Region(2020-2025)
12.2 Global Influenza Therapeutics Revenue Market Share by Region (2020-2025)
12.3 Global Influenza Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Influenza Therapeutics Production
12.4.1 North America Influenza Therapeutics Production Growth Rate (2020-2025)
12.4.2 North America Influenza Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Influenza Therapeutics Production
12.5.1 Europe Influenza Therapeutics Production Growth Rate (2020-2025)
12.5.2 Europe Influenza Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Influenza Therapeutics Production (2020-2025)
12.6.1 Japan Influenza Therapeutics Production Growth Rate (2020-2025)
12.6.2 Japan Influenza Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Influenza Therapeutics Production (2020-2025)
12.7.1 China Influenza Therapeutics Production Growth Rate (2020-2025)
12.7.2 China Influenza Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
13 Influenza Therapeutics Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Influenza Therapeutics Sales Market Share by Type (2020-2033)
13.3 Global Influenza Therapeutics Market Size Market Share by Type (2020-2033)
13.4 Global Influenza Therapeutics Price by Type (2020-2033)
14 Influenza Therapeutics Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Influenza Therapeutics Market Sales by Application (2020-2033)
14.3 Global Influenza Therapeutics Market Size (M USD) by Application (2020-2033)
14.4 Global Influenza Therapeutics Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 Abbott Laboratories
15.1.1 Abbott Laboratories Basic Information
15.1.2 Abbott Laboratories Influenza Therapeutics Product Overview
15.1.3 Abbott Laboratories Influenza Therapeutics Product Market Performance
15.1.4 Abbott Laboratories Business Overview
15.1.5 Abbott Laboratories SWOT Analysis
15.1.6 Abbott Laboratories Recent Developments
15.2 Astrazeneca PLC
15.2.1 Astrazeneca PLC Basic Information
15.2.2 Astrazeneca PLC Influenza Therapeutics Product Overview
15.2.3 Astrazeneca PLC Influenza Therapeutics Product Market Performance
15.2.4 Astrazeneca PLC Business Overview
15.2.5 Astrazeneca PLC SWOT Analysis
15.2.6 Astrazeneca PLC Recent Developments
15.3 Biocryst Pharmaceuticals
15.3.1 Biocryst Pharmaceuticals Basic Information
15.3.2 Biocryst Pharmaceuticals Influenza Therapeutics Product Overview
15.3.3 Biocryst Pharmaceuticals Influenza Therapeutics Product Market Performance
15.3.4 Biocryst Pharmaceuticals Business Overview
15.3.5 Biocryst Pharmaceuticals SWOT Analysis
15.3.6 Biocryst Pharmaceuticals Recent Developments
15.4 Inc.
15.4.1 Inc. Basic Information
15.4.2 Inc. Influenza Therapeutics Product Overview
15.4.3 Inc. Influenza Therapeutics Product Market Performance
15.4.4 Inc. Business Overview
15.4.5 Inc. Recent Developments
15.5 Chiron Corporation
15.5.1 Chiron Corporation Basic Information
15.5.2 Chiron Corporation Influenza Therapeutics Product Overview
15.5.3 Chiron Corporation Influenza Therapeutics Product Market Performance
15.5.4 Chiron Corporation Business Overview
15.5.5 Chiron Corporation Recent Developments
15.6 CSL Limited
15.6.1 CSL Limited Basic Information
15.6.2 CSL Limited Influenza Therapeutics Product Overview
15.6.3 CSL Limited Influenza Therapeutics Product Market Performance
15.6.4 CSL Limited Business Overview
15.6.5 CSL Limited Recent Developments
15.7 Daiichi Sankyo Co.
15.7.1 Daiichi Sankyo Co. Basic Information
15.7.2 Daiichi Sankyo Co. Influenza Therapeutics Product Overview
15.7.3 Daiichi Sankyo Co. Influenza Therapeutics Product Market Performance
15.7.4 Daiichi Sankyo Co. Business Overview
15.7.5 Daiichi Sankyo Co. Recent Developments
15.8 Ltd.
15.8.1 Ltd. Basic Information
15.8.2 Ltd. Influenza Therapeutics Product Overview
15.8.3 Ltd. Influenza Therapeutics Product Market Performance
15.8.4 Ltd. Business Overview
15.8.5 Ltd. Recent Developments
15.9 Glaxosmithkline PLC
15.9.1 Glaxosmithkline PLC Basic Information
15.9.2 Glaxosmithkline PLC Influenza Therapeutics Product Overview
15.9.3 Glaxosmithkline PLC Influenza Therapeutics Product Market Performance
15.9.4 Glaxosmithkline PLC Business Overview
15.9.5 Glaxosmithkline PLC Recent Developments
15.10 Mitsubishi Tanabe Pharma Corporation
15.10.1 Mitsubishi Tanabe Pharma Corporation Basic Information
15.10.2 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product Overview
15.10.3 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product Market Performance
15.10.4 Mitsubishi Tanabe Pharma Corporation Business Overview
15.10.5 Mitsubishi Tanabe Pharma Corporation Recent Developments
15.11 Nanotherapeutics Inc.
15.11.1 Nanotherapeutics Inc. Basic Information
15.11.2 Nanotherapeutics Inc. Influenza Therapeutics Product Overview
15.11.3 Nanotherapeutics Inc. Influenza Therapeutics Product Market Performance
15.11.4 Nanotherapeutics Inc. Business Overview
15.11.5 Nanotherapeutics Inc. Recent Developments
15.12 Protein Sciences Corporation
15.12.1 Protein Sciences Corporation Basic Information
15.12.2 Protein Sciences Corporation Influenza Therapeutics Product Overview
15.12.3 Protein Sciences Corporation Influenza Therapeutics Product Market Performance
15.12.4 Protein Sciences Corporation Business Overview
15.12.5 Protein Sciences Corporation Recent Developments
15.13 Roche Holding AG
15.13.1 Roche Holding AG Basic Information
15.13.2 Roche Holding AG Influenza Therapeutics Product Overview
15.13.3 Roche Holding AG Influenza Therapeutics Product Market Performance
15.13.4 Roche Holding AG Business Overview
15.13.5 Roche Holding AG Recent Developments
15.14 Sanofi SA
15.14.1 Sanofi SA Basic Information
15.14.2 Sanofi SA Influenza Therapeutics Product Overview
15.14.3 Sanofi SA Influenza Therapeutics Product Market Performance
15.14.4 Sanofi SA Business Overview
15.14.5 Sanofi SA Recent Developments
15.15 Shionogi and Co.
15.15.1 Shionogi and Co. Basic Information
15.15.2 Shionogi and Co. Influenza Therapeutics Product Overview
15.15.3 Shionogi and Co. Influenza Therapeutics Product Market Performance
15.15.4 Shionogi and Co. Business Overview
15.15.5 Shionogi and Co. Recent Developments
15.16 Ltd.
15.16.1 Ltd. Basic Information
15.16.2 Ltd. Influenza Therapeutics Product Overview
15.16.3 Ltd. Influenza Therapeutics Product Market Performance
15.16.4 Ltd. Business Overview
15.16.5 Ltd. Recent Developments
15.17 Sinovac Biotech Ltd.
15.17.1 Sinovac Biotech Ltd. Basic Information
15.17.2 Sinovac Biotech Ltd. Influenza Therapeutics Product Overview
15.17.3 Sinovac Biotech Ltd. Influenza Therapeutics Product Market Performance
15.17.4 Sinovac Biotech Ltd. Business Overview
15.17.5 Sinovac Biotech Ltd. Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Influenza Therapeutics Market Size by Type (M USD)
Table 4. Global Influenza Therapeutics Market Size by Application (M USD)
Table 5. Influenza Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global Influenza Therapeutics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Influenza Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Influenza Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Influenza Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Therapeutics as of 2024)
Table 11. Global Market Influenza Therapeutics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Influenza Therapeutics Manufacturing Sites and Area Served
Table 13. Manufacturers Influenza Therapeutics Product Type
Table 14. Global Influenza Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Influenza Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Influenza Therapeutics Market Size Comparison by Region (M USD)
Table 26. Global Influenza Therapeutics Market Size by Region (2020-2033) & (M USD)
Table 27. Global Influenza Therapeutics Market Size Market Share by Region (2020-2033)
Table 28. Global Influenza Therapeutics Sales by Region (2020-2033) & (K Units)
Table 29. Global Influenza Therapeutics Sales Market Share by Region (2020-2033)
Table 30. North America Influenza Therapeutics Market Size by Country (2020-2033) & (M USD)
Table 31. North America Influenza Therapeutics Sales by Country (2020-2033) & (K Units)
Table 32. North America Influenza Therapeutics Sales by Type (K Units)
Table 33. North America Influenza Therapeutics Market Size by Type (M USD)
Table 34. North America Influenza Therapeutics Sales (K Units) by Type (2020-2033)
Table 35. North America Influenza Therapeutics Market Size (M USD) by Type (2020-2033)
Table 36. North America Influenza Therapeutics Sales by Application (K Units)
Table 37. North America Influenza Therapeutics Market Size by Application (M USD)
Table 38. North America Influenza Therapeutics Sales (K Units) by Application (2020-2033)
Table 39. North America Influenza Therapeutics Market Size (M USD) by Application (2020-2033)
Table 40. Europe Influenza Therapeutics Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Influenza Therapeutics Sales by Country (2020-2033) & (K Units)
Table 42. Europe Influenza Therapeutics Sales by Type (K Units)
Table 43. Europe Influenza Therapeutics Market Size by Type (M USD)
Table 44. Europe Influenza Therapeutics Sales (K Units) by Type (2020-2033)
Table 45. Europe Influenza Therapeutics Market Size (M USD) by Type (2020-2033)
Table 46. Europe Influenza Therapeutics Sales by Application (K Units)
Table 47. Europe Influenza Therapeutics Market Size by Application (M USD)
Table 48. Europe Influenza Therapeutics Sales (K Units) by Application (2020-2033)
Table 49. Europe Influenza Therapeutics Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Influenza Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Influenza Therapeutics Sales by Country (2020-2025) & (K Units)
Table 52. Asia-Pacific Influenza Therapeutics Sales by Type (K Units)
Table 53. Asia-Pacific Influenza Therapeutics Market Size by Type (M USD)
Table 54. Asia-Pacific Influenza Therapeutics Sales (K Units) by Type (2020-2033)
Table 55. Asia-Pacific Influenza Therapeutics Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Influenza Therapeutics Sales by Application (K Units)
Table 57. Asia-Pacific Influenza Therapeutics Market Size by Application (M USD)
Table 58. Asia-Pacific Influenza Therapeutics Sales (K Units) by Application (2020-2033)
Table 59. Asia-Pacific Influenza Therapeutics Market Size (M USD) by Application (2020-2025)
Table 60. South America Influenza Therapeutics Market Size by Country (2020-2033) & (M USD)
Table 61. South America Influenza Therapeutics Sales by Country (2020-2033) & (K Units)
Table 62. South America Influenza Therapeutics Sales by Type (K Units)
Table 63. South America Influenza Therapeutics Market Size by Type (M USD)
Table 64. South America Influenza Therapeutics Sales (K Units) by Type (2020-2033)
Table 65. South America Influenza Therapeutics Market Size (M USD) by Type (2020-2033)
Table 66. South America Influenza Therapeutics Sales by Application (K Units)
Table 67. South America Influenza Therapeutics Market Size by Application (M USD)
Table 68. South America Influenza Therapeutics Sales (K Units) by Application (2020-2033)
Table 69. South America Influenza Therapeutics Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Influenza Therapeutics Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Influenza Therapeutics Sales by Country (2020-2033) & (K Units)
Table 72. Middle East and Africa Influenza Therapeutics Sales by Type (K Units)
Table 73. Middle East and Africa Influenza Therapeutics Market Size by Type (M USD)
Table 74. Middle East and Africa Influenza Therapeutics Sales (K Units) by Type (2020-2033)
Table 75. Middle East and Africa Influenza Therapeutics Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Influenza Therapeutics Sales by Application (K Units)
Table 77. Middle East and Africa Influenza Therapeutics Market Size by Application (M USD)
Table 78. Middle East and Africa Influenza Therapeutics Sales (K Units) by Application (2020-2033)
Table 79. Middle East and Africa Influenza Therapeutics Market Size (M USD) by Application (2020-2033)
Table 80. Global Influenza Therapeutics Production (K Units) by Region(2020-2025)
Table 81. Global Influenza Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Influenza Therapeutics Revenue Market Share by Region (2020-2025)
Table 83. Global Influenza Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. North America Influenza Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Europe Influenza Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Japan Influenza Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. China Influenza Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Global Influenza Therapeutics Sales by Type (K Units)
Table 89. Global Influenza Therapeutics Market Size by Type (M USD)
Table 90. Global Influenza Therapeutics Sales (K Units) by Type (2020-2033)
Table 91. Global Influenza Therapeutics Sales Market Share by Type (2020-2033)
Table 92. Global Influenza Therapeutics Market Size (M USD) by Type (2020-2033)
Table 93. Global Influenza Therapeutics Market Size Share by Type (2020-2033)
Table 94. Global Influenza Therapeutics Sales (K Units) by Application
Table 95. Global Influenza Therapeutics Market Size by Application(M USD)
Table 96. Global Influenza Therapeutics Sales by Application (2020-2033) & (K Units)
Table 97. Global Influenza Therapeutics Sales Market Share by Application (2020-2033)
Table 98. Global Influenza Therapeutics Market Size by Application (2020-2033) & (M USD)
Table 99. Global Influenza Therapeutics Market Share by Application (2020-2033)
Table 100. Global Influenza Therapeutics Sales Growth Rate by Application (2020-2033)
Table 101. Abbott Laboratories Basic Information
Table 102. Abbott Laboratories Influenza Therapeutics Product Overview
Table 103. Abbott Laboratories Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Abbott Laboratories Business Overview
Table 105. Abbott Laboratories SWOT Analysis
Table 106. Abbott Laboratories Recent Developments
Table 107. Astrazeneca PLC Basic Information
Table 108. Astrazeneca PLC Influenza Therapeutics Product Overview
Table 109. Astrazeneca PLC Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Astrazeneca PLC Business Overview
Table 111. Astrazeneca PLC SWOT Analysis
Table 112. Astrazeneca PLC Recent Developments
Table 113. Biocryst Pharmaceuticals Basic Information
Table 114. Biocryst Pharmaceuticals Influenza Therapeutics Product Overview
Table 115. Biocryst Pharmaceuticals Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Biocryst Pharmaceuticals Business Overview
Table 117. Biocryst Pharmaceuticals SWOT Analysis
Table 118. Biocryst Pharmaceuticals Recent Developments
Table 119. Inc. Basic Information
Table 120. Inc. Influenza Therapeutics Product Overview
Table 121. Inc. Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Inc. Business Overview
Table 123. Inc. Recent Developments
Table 124. Chiron Corporation Basic Information
Table 125. Chiron Corporation Influenza Therapeutics Product Overview
Table 126. Chiron Corporation Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Chiron Corporation Business Overview
Table 128. Chiron Corporation Recent Developments
Table 129. CSL Limited Basic Information
Table 130. CSL Limited Influenza Therapeutics Product Overview
Table 131. CSL Limited Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. CSL Limited Business Overview
Table 133. CSL Limited Recent Developments
Table 134. Daiichi Sankyo Co. Basic Information
Table 135. Daiichi Sankyo Co. Influenza Therapeutics Product Overview
Table 136. Daiichi Sankyo Co. Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Daiichi Sankyo Co. Business Overview
Table 138. Daiichi Sankyo Co. Recent Developments
Table 139. Ltd. Basic Information
Table 140. Ltd. Influenza Therapeutics Product Overview
Table 141. Ltd. Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Ltd. Business Overview
Table 143. Ltd. Recent Developments
Table 144. Glaxosmithkline PLC Basic Information
Table 145. Glaxosmithkline PLC Influenza Therapeutics Product Overview
Table 146. Glaxosmithkline PLC Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Glaxosmithkline PLC Business Overview
Table 148. Glaxosmithkline PLC Recent Developments
Table 149. Mitsubishi Tanabe Pharma Corporation Basic Information
Table 150. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product Overview
Table 151. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Mitsubishi Tanabe Pharma Corporation Business Overview
Table 153. Mitsubishi Tanabe Pharma Corporation Recent Developments
Table 154. Nanotherapeutics Inc. Basic Information
Table 155. Nanotherapeutics Inc. Influenza Therapeutics Product Overview
Table 156. Nanotherapeutics Inc. Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 157. Nanotherapeutics Inc. Business Overview
Table 158. Nanotherapeutics Inc. Recent Developments
Table 159. Protein Sciences Corporation Basic Information
Table 160. Protein Sciences Corporation Influenza Therapeutics Product Overview
Table 161. Protein Sciences Corporation Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 162. Protein Sciences Corporation Business Overview
Table 163. Protein Sciences Corporation Recent Developments
Table 164. Roche Holding AG Basic Information
Table 165. Roche Holding AG Influenza Therapeutics Product Overview
Table 166. Roche Holding AG Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 167. Roche Holding AG Business Overview
Table 168. Roche Holding AG Recent Developments
Table 169. Sanofi SA Basic Information
Table 170. Sanofi SA Influenza Therapeutics Product Overview
Table 171. Sanofi SA Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 172. Sanofi SA Business Overview
Table 173. Sanofi SA Recent Developments
Table 174. Shionogi and Co. Basic Information
Table 175. Shionogi and Co. Influenza Therapeutics Product Overview
Table 176. Shionogi and Co. Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 177. Shionogi and Co. Business Overview
Table 178. Shionogi and Co. Recent Developments
Table 179. Ltd. Basic Information
Table 180. Ltd. Influenza Therapeutics Product Overview
Table 181. Ltd. Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 182. Ltd. Business Overview
Table 183. Ltd. Recent Developments
Table 184. Sinovac Biotech Ltd. Basic Information
Table 185. Sinovac Biotech Ltd. Influenza Therapeutics Product Overview
Table 186. Sinovac Biotech Ltd. Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 187. Sinovac Biotech Ltd. Business Overview
Table 188. Sinovac Biotech Ltd. Recent Developments
List of Figures
Figure 1. Product Picture of Influenza Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Influenza Therapeutics Market Size (M USD), 2024-2033
Figure 5. Global Influenza Therapeutics Market Size (M USD) (2020-2033)
Figure 6. Global Influenza Therapeutics Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Influenza Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Influenza Therapeutics Product Life Cycle
Figure 13. Influenza Therapeutics Sales Share by Manufacturers in 2024
Figure 14. Global Influenza Therapeutics Revenue Share by Manufacturers in 2024
Figure 15. Influenza Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Influenza Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Influenza Therapeutics Revenue in 2024
Figure 18. Industry Chain Map of Influenza Therapeutics
Figure 19. Global Influenza Therapeutics Market PEST Analysis
Figure 20. Global Influenza Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Influenza Therapeutics Market Size by Region
Figure 27. Global Influenza Therapeutics Market Size Market Share by Region (2020-2033)
Figure 28. Global Influenza Therapeutics Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Influenza Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 31. North America Influenza Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Influenza Therapeutics Market Size (M USD) by Country
Figure 33. USA Influenza Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 34. USA Influenza Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Influenza Therapeutics Sales (K Units) and Growth Rate (2020-2033)
Figure 36. Canada Influenza Therapeutics Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Influenza Therapeutics Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Influenza Therapeutics Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Influenza Therapeutics Market Size (M USD)by Type
Figure 40. North America Influenza Therapeutics Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Influenza Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 43. Europe Influenza Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Influenza Therapeutics Market Size (M USD) by Country
Figure 45. Germany Influenza Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 46. Germany Influenza Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Influenza Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 48. France Influenza Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Influenza Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 50. U.K. Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Influenza Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 52. Italy Influenza Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Influenza Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 54. Spain Influenza Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Influenza Therapeutics Market Size (M USD) by Type
Figure 56. Europe Influenza Therapeutics Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Influenza Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 59. Asia-Pacific Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Influenza Therapeutics Market Size (M USD) by Country
Figure 61. China Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. China Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Japan Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 66. South Korea Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 68. India Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 70. Southeast Asia Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Influenza Therapeutics Market Size (M USD) by Type
Figure 72. Asia-Pacific Influenza Therapeutics Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Influenza Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 75. South America Influenza Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Influenza Therapeutics Market Size (M USD) by Country
Figure 77. Brazil Influenza Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 78. Brazil Influenza Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Influenza Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 80. Argentina Influenza Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Influenza Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 82. Columbia Influenza Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Influenza Therapeutics Market Size (M USD) by Type
Figure 84. South America Influenza Therapeutics Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Influenza Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 87. Middle East and Africa Influenza Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Influenza Therapeutics Market Size (M USD) by Country
Figure 89. Saudi Arabia Influenza Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 90. Saudi Arabia Influenza Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Influenza Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 92. UAE Influenza Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Influenza Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 94. Egypt Influenza Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Influenza Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 96. Nigeria Influenza Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Influenza Therapeutics Sales and Growth Rate (2020-2033) & (K Units)
Figure 98. South Africa Influenza Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Influenza Therapeutics Market Size (M USD) by Type
Figure 100. Middle East and Africa Influenza Therapeutics Market Size (M USD) by Application
Figure 101. Global Influenza Therapeutics Production Market Share by Region (2020-2025)
Figure 102. North America Influenza Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 103. Europe Influenza Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 104. Japan Influenza Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 105. China Influenza Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Influenza Therapeutics Market Size by Type (M USD)
Figure 108. Sales Market Share of Influenza Therapeutics by Type (2020-2033)
Figure 109. Sales Market Share of Influenza Therapeutics by Type in 2024
Figure 110. Market Size Share of Influenza Therapeutics by Type (2020-2033)
Figure 111. Market Size Share of Influenza Therapeutics by Type in 2024
Figure 112. Global Influenza Therapeutics Price (USD/Unit) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Influenza Therapeutics Market Size by Application(M USD)
Figure 115. Global Influenza Therapeutics Market Share by Application
Figure 116. Global Influenza Therapeutics Sales Market Share by Application (2020-2033)
Figure 117. Global Influenza Therapeutics Sales Market Share by Application in 2024
Figure 118. Global Influenza Therapeutics Market Share by Application (2020-2033)
Figure 119. Global Influenza Therapeutics Market Share by Application in 2024
Figure 120. Global Influenza Therapeutics Sales Growth Rate by Application (2020-2033)